Idiopathic pulmonary fibrosis management
Summary
Idiopathic pulmonary fibrosis causes irreversible damage to the lungs, and pharmacological cure is not possible. Patients who are diagnosed with the disease have complex management needs and should be cared for by specialist multidisciplinary teams.
Treatment is aimed at slowing the progression of the disease, alleviating symptoms, preventing exacerbations and improving quality of life. Oxygen therapy and pulmonary rehabilitation are currently the main treatment options and an increasing number of pharmacological options aimed at slowing disease progression are becoming available.
Lloyd Mayers is a respiratory pharmacist at North Bristol NHS Trust and Patricia Ging is transplant and pulmonary hypertension pharmacist at Mater Misericordiae University Hospital in Dublin, Ireland.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2013.11127259
Recommended from Pharmaceutical Press
- Previous
- Next
Strategic Medicines Management
A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.
£33.00Buy now.jpg)
Adverse Drug Reactions
A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.
£38.00Buy now
Obesity Epidemic and Its Management (The)
The Obesity Epidemic and its Management explains the causes, dangers and treatments of obesity.
£38.00Buy now
Financial Analysis in Pharmacy Practice
An introduction to the basics of accounting and financial management. Applies these principles to pharmacy practice.
£38.00Buy now
Essentials of Pharmacy Management
Essentials of Pharmacy Management is an accessible introduction to management. It provides a jump-start to leadership roles and career advancement.
£43.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.